GlassScriptPhysician profile
Nancy E Hughes
NPI 1225197791
$1,945.79
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $483 · 2021: $586 · 2022: $156.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $372.47 | 2019-2021 | |
| Amgen INC. | $270.56 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $234.18 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $207.17 | 2019-2021 | |
| Lilly USA, LLC | $205.11 | 2019-2022 | |
| Merz North America, INC. | $168.08 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.18 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $59.73 | 2019-2021 | |
| Esperion Therapeutics, INC. | $54.79 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.11 | 2019-2021 | |
| Ascensia Diabetes Care US INC. | $39.80 | 2020 | |
| Janssen Pharmaceuticals, INC | $34.12 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $21.32 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.38 | 2022 | |
| Eisai INC. | $19.26 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.91 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.39 | 2019 | |
| Currax Pharmaceuticals LLC | $13.64 | 2021 | |
| Pfizer INC. | $12.67 | 2019 | |
| Merck Sharp & Dohme LLC | $12.62 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.